Outcomes of Renal Replacement in Mexico
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
About this trial
A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Willingness to participate and provision of written informed consent
Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months
Availability of a medical record containing information on the study variables
Receiving care at one of the participating centers
Disqualifiers
Life expectancy <3 months due to a cause unrelated to chronic kidney disease
Trial population
Patients with chronic kidney disease undergoing hemodialysis or peritoneal dialysis in the units participating in the project
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
290 Participants
are grouped into 1 trial groupGroup A: CKD on RRT
Trial outcomes
Primary outcomes
1
All-cause mortality
The occurrence of death from any cause during the follow-up period, as documented in the patient's medical record
Time frame
From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.Secondary outcomes
1
Hospitalizations per patient-year
The number of hospitalizations recorded during the study follow-up, expressed per patient-year
Time frame
From enrollment until the end of follow-up, assessed up to 3 years2
Infection rate
The number of documented infection episodes during the follow-up period, as recorded in the medical records, expressed per patient-year.
Time frame
From enrollment until the end of follow-up, assessed up to 3 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: